CommercialCoverageLow impact
Preconceptional Sex Selection Techniques (CPB 0323, reviewed 2026-05-20)
Aetna·OB-GYN, Genetics, Internal Medicine·Medical Policy
Effective date
May 20, 2026
We identified it
Aug 13, 2026
Summary
Aetna's policy on preconceptional sex selection techniques (CPB 0323, effective 2026-05-20) clarifies that sperm sorting for sex selection is covered only when medically necessary to prevent conception of a male child in women who are carriers of serious X-linked genetic disorders (e.g., Lesch-Nyhan disease). Sex selection for personal, social, or cultural reasons—including family balancing—is not covered. Assisted reproductive techniques (IVF, ICSI) used solely for sex selection without genetic disease prevention are excluded from coverage.
Action Required
By 2026-05-20: Billing and authorization teams must implement the following controls for Aetna members: (1) Require medical documentation from providers confirming the patient is a known carrier of a serious X-linked genetic disorder (e.g., Lesch-Nyhan disease) before approving claims for CPT codes 89261, 89268, 88182-88189 (sperm sorting, flow cytometry) or S4011-S4042 (IVF/ART services); (2) Deny or request medical necessity clarification for any preconceptional sex selection claims where the indication is family balancing, personal preference, or sex selection without documented genetic disease prevention; (3) Update billing system edits to flag claims for sperm sorting and assisted reproductive procedures with ICD-10 codes related to X-linked carrier status (e.g., Z15.0x for genetic counseling regarding heritable disease); (4) Train prior authorization staff to distinguish between medically necessary sex selection for genetic disease prevention (covered) versus non-medical sex selection (not covered); (5) Communicate policy to in-network providers, particularly fertility specialists and ob-gyns. Failure to enforce these controls may result in inappropriate claim payments for non-covered services.